Разработка инновационных препаратов для современных медицинских потребностей. →
Производство антибиотиков и витаминов с учетом современных стандартов. →
This AI Paper Introduces the Kolmogorov-Test: A Compression-as-Intelligence Benchmark for Evaluating Code-Generating Language Models Compression is a cornerstone of computational intelligence, deeply rooted in the theory of Kolmogorov complexity, which defines the minimal program needed to reproduce a given sequence. Unlike traditional compression methods that look for repetition and redundancy, Kolmogorov’s framework interprets compression as… →

LTV (Lifetime Value) – Пожизненная ценность клиента. Общее количество денег, которое клиент принесёт за всё время использования продукта. Как рассчитать LTV и почему он важен для оценки долгосрочной ценности клиентов. #Продукт #Продуктовыймененджмент #ИИМаркетинг #Менеджмент #ИИМенеджмент →

Google DeepMind Researchers Propose CaMeL: A Robust Defense that Creates a Protective System Layer around the LLM, Securing It even when Underlying Models may be Susceptible to Attacks Large Language Models (LLMs) are becoming integral to modern technology, driving agentic systems that interact dynamically with external environments. Despite their impressive capabilities, LLMs are highly vulnerable… →
GitHub Copilot is an AI-powered coding assistant integrated into the developer environment It suggests code snippets and entire functions based on context significantly speeding up software development cycles Companies using Copilot report a 50% reduction in coding time which translates to faster product launches and reduced labor expenses By minimizing manual coding errors debugging time… →

Kano Model – Метод анализа фич. Моделирование потребностей пользователей в трёх категориях: базовые, удовлетворяющие и вау-эффекты. Как эти категории помогают принимать решения при добавлении новых функций в продукт. #ИИМаркетинг #Менеджмент #Продукт #Продуктовыймененджмент #ИИМенеджмент →

CONCLUSION: Heart rate variability biofeedback is a feasible intervention for addressing diverse chronic symptoms commonly reported by breast cancer survivors. →

JS005 is a novel anti-IL-17A monoclonal antibody. A Phase Ia study (Study 1) in healthy adults, followed by a Phase Ib/II study (Study 2) in patients with moderate to severe plaque psoriasis (PsO), were designed to evaluate the safety, efficacy, and pharmacokinetic characteristics of JS005. Study 1 was a double-blind, randomized, placebo-controlled, single dose-escalation (15,… →

CONCLUSIONS: Sirolimus may reduce VA tissue volume and potentially improve symptoms and activities of daily living in patients with VAs. →
